ABBV vs LLY: stock comparison and AI forecast
Abbvie Inc. (ABBV) and Eli Lilly & Co (LLY) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ABBV Abbvie Inc.
- Price
- $294.89 +39.5% · 6M
- Market Cap
- $521.00B
- P/E Ratio
- 45.2x
- Size
- mega-cap
- AI Forecast
LLY Eli Lilly & Co
- Market Cap
- $1.33T
- P/E Ratio
- 45.7x
- Size
- mega-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- LLY is 2.5 times larger than ABBV by market capitalization ($1.33T against $521.00B).
- ABBV trades at 45.1 times trailing earnings, LLY at 45.7 times.
- ABBV yields 2.33% in dividends and LLY 0.45%.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ABBV | LLY |
|---|---|---|
| Market Cap | $521.00B | $1.33T |
| P/E Ratio | 45.15x | 45.74x |
| P/B Ratio | – | 134.90x |
| Dividend Yield | 2.33% | 0.45% |
| EPS | $6.53 | $30.81 |
| Book Value/Share | – | $10.45 |
| Revenue/Share | $37.36 | $91.91 |
| FCF/Share | $10.68 | – |
Profitability & Margins
| Metric | ABBV | LLY |
|---|---|---|
| ROA | 7.0% | – |
| ROIC | 20.3% | – |
| Gross Margin | 73.7% | 83.6% |
| Operating Margin | 32.2% | – |
| Net Margin | 15.7% | – |
| EBT Margin | 19.4% | 135.0% |
| Tax Rate | 19.2% | 20.7% |
Financial Health
| Metric | ABBV | LLY |
|---|---|---|
| Current Ratio | 0.87x | 1.39x |
| Quick Ratio | 0.75x | 1.00x |
| D/E Ratio | – | 3.36x |
| Interest Coverage | 7.8x | – |
| Working Capital | -$5.62B | $18.27B |
Cash Flow
| Metric | ABBV | LLY |
|---|---|---|
| Operating Cash Flow | $20.09B | $30.64B |
| Free Cash Flow | $18.87B | – |
| Capital Spending | -$1.22B | – |
| OCF Growth YoY | -3.7% | 90.8% |
| FCF Growth YoY | -4.1% | – |
| FCF/Sales | 28.6% | – |
| CapEx/Sales | 1.8% | – |
Operational Efficiency
| Metric | ABBV | LLY |
|---|---|---|
| Asset Turnover | 0.45x | – |
| Receivables Turnover | 4.9x | 3.9x |
| Inventory Turnover | 3.3x | 0.8x |
| Fixed Assets Turnover | 11.1x | 2.7x |
| Days Sales Outstanding | 75 days | 93 days |
| Days Inventory | 112 days | 469 days |
| Payables Period | 724 days | 149 days |
| Cash Conversion Cycle | -538 days | 413 days |
Income Statement
| Metric | ABBV | LLY |
|---|---|---|
| Total Revenue | $66.01B | $86.46B |
| Operating Income | $21.23B | – |
| Net Income | $10.34B | – |
| R&D Expense | $9.96B | $15.38B |
| SG&A Expense | $15.19B | $12.62B |
| Cost of Goods Sold | $17.35B | $14.15B |
Dividend & Shareholder Information
| Metric | ABBV | LLY |
|---|---|---|
| Dividends Per Share | $6.87 | $6.36 |
| Payout Ratio | 105.2% | 20.6% |
| Shares Outstanding | 1767M | 941M |
| Net Income Growth | 333.1% | – |
| EPS Growth | 380.1% | 50.7% |
ABBV vs LLY: stock comparison and AI forecast
Which is bigger, ABBV or LLY?
LLY is 2.5 times larger than ABBV by market capitalization ($1.33T against $521.00B).
Which is cheaper on earnings, ABBV or LLY?
ABBV trades at 45.1 times trailing earnings, LLY at 45.7 times.
Which one does Intratio's AI model rank higher, ABBV or LLY?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.